SCHEMBL2407334

SCHEMBL2407334

CC(C)c1cc(C(=O)Nc2ccc3[nH]c(C(=O)O)cc3c2)oc1C(C)C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EIF4A3 P38919 2/20 0.44
NPC1 O15118 5/20 0.44
RAB9A P51151 4/20 0.44
MAPT P10636 3/20 0.44
KMT2A Q03164 3/20 0.44
ALDH1A1 P00352 2/20 0.44
HPGD P15428 2/20 0.44
MEN1 O00255 2/20 0.44
SMAD3 P84022 1/20 0.44
PIN1 Q13526 1/20 0.43
NHERF1 O14745 3/20 0.42
TP53 P04637 2/20 0.42
POLB P06746 1/20 0.42
MAOA P21397 1/20 0.42
MAOB P27338 1/20 0.42
KDM4E B2RXH2 3/20 0.41
RXFP1 Q9HBX9 1/20 0.41
F7 P08709 1/20 0.40
F3 P13726 1/20 0.40
PDPK1 O15530 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2407549 0.86 MMP13 (0.61) NPC1RAB9AMAPTKMT2AALDH1A1
SCHEMBL8210586 0.81 SMAD3 (0.51) NPC1RAB9AMAPTKMT2AALDH1A1
SCHEMBL2406820 0.78 NPC1 (0.53) NPC1RAB9AKMT2AALDH1A1HPGD
SCHEMBL27520204 0.77 NPC1 (0.53) NPC1RAB9AMAPTKMT2AALDH1A1
SCHEMBL5733671 0.76 RAB9A (0.62) NPC1RAB9AMAPTKMT2AALDH1A1
SCHEMBL2405520 0.76 PKM (0.51) NPC1RAB9AMAPTKMT2AALDH1A1
SCHEMBL2411251 0.76 RARA (0.46) NPC1RAB9AMAPTKMT2AALDH1A1
SCHEMBL3043508 0.76 PTPN1 (0.51) NPC1RAB9AMAPTKMT2AALDH1A1
SCHEMBL2405034 0.75 AKR1C3 (0.44) NPC1RAB9AMAPTKMT2AALDH1A1
SCHEMBL5679468 0.75 FLT3 (0.51) NPC1RAB9AMAPTKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8722730-B2 5-membered heterocyclic compound RESEARCH FOUNDATION ITSUU LABORATORY (JP) 2014-05-13 US disclosed
US-8722730-B2 5-membered heterocyclic compound RESEARCH FOUNDATION ITSUU LABORATORY (JP) 2014-05-13 US disclosed
US-20110213156-A1 5-MEMBERED HETEROCYCLIC COMPOUND RESEARCH FOUNDATION ITSUU LABORATORY (JP) 2011-09-01 US disclosed
US-20110213156-A1 5-MEMBERED HETEROCYCLIC COMPOUND RESEARCH FOUNDATION ITSUU LABORATORY (JP) 2011-09-01 US disclosed
EP-2189445-A1 FIVE-MEMBERED HETEROCYCLIC COMPOUND Research Foundation Itsuu Laboratory (JP) 2010-05-26 EP disclosed
EP-2189445-A1 FIVE-MEMBERED HETEROCYCLIC COMPOUND Research Foundation Itsuu Laboratory (JP) 2010-05-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110213156-A1 5-MEMBERED HETEROCYCLIC COMPOUND RXRA, RXRG, RXRB EIF4A3 3298/4885NPC1 692/4885RAB9A 542/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.